|
español |
|
|
|
|
||
![]() Click here to visit the pharmacy |
![]() |
![]() Click here to visit the pharmacy |
|||||||||
Some of the Indian Pharmacy prices: |
Some of the Worldwide Pharmacy prices: |
||||||||||
|
|
||||||||||
|
BEST SELLERS |
|||||||||||
|
INSOMNIA Ambien (brand name) and zolpidem (generic Ambien) |
TOO MUCH ACID IN STOMACH (ulcers, reflux disease - GERD or heartburn) Nexium (brand name) and esomeprazole (generic Nexium)Prevacid (brand name) and lansoprazole (generic Prevacid)Prilosec (brand name) and omeprazole (generic Prilosec)Protonix (brand name) and pantoprazole (generic Protonix)Zantac (brand name) and ranitidine (generic Zantac) |
||||||||||
|
MIGRAINES AND HEADACHES Imitrex (brand name) and sumatriptan (generic Imitrex) |
|||||||||||
|
FERTILITY Clomid (brand name) and clomiphene (generic Clomid) |
|||||||||||
|
NARCOLEPSY Modalert (brand name) and modafinil (generic Modalert) |
ERECTILE DYSFUNCTION (ED)- IMPOTENCE Viagra (brand name) and sildenafil citrate (generic Viagra) |
||||||||||
|
• Fri, Oct 3, 2008 -
FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine-related Compounds in Food . The U.S. Food and Drug Administration (FDA) today issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula. • Tue, Sep 30, 2008 - FDA Awards $5.2 Million in Grants to Further Food and Feed Safety. The U.S. Food and Drug Administration today announced the awarding of 17 grants to enhance food and feed safety. These grants fund major cooperative agreements in four major areas. The FDA awarded a combined $5.2 million in these one-year grants to various state and local regulatory agencies. • Tue, Sep 30, 2008 - FDA Awards up to $2.5 Billion to Modernize Information Technology over Ten Years. The U.S. Food and Drug Administration today announced the selection of ten contractors to receive up to a total of $2.5 billion for information technology (IT) and data center management services over the next ten years. • Mon, Sep 29, 2008 - FDA Analysis Shows Cholesterol Lowering Medications Do Not Increase the Risk of Lou Gehrig's Disease. A U.S. Food and Drug Administration's analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as Lou Gehrig's Disease. |
• What are Generic Drugs? - FDA information about generic drugs
/
FDA Q&A about generic drugs |